Dear jen: The decision of whether to do chemotherapy and what drugs to use depends on many
factorsFactor ix complex including the size of the tumor, whether there are lymph
nodesLymph node biopsy
Swollen glands
Swollen lymph nodes in the groin
Swollen lymph nodes under arm involved, and the health of the patient, to name several. In general, the decision is made based on a risk versus benefit ratio. This may differ by physician and to the person for whom the chemotherapy is recommended. CEF is not commonly used in the US. The most
commonCommon cold regimen in the US is AC. AC and CEF regimens have never been directly compared but each has been compared to the old standard 'CMF' regimen in well designed clinical trials. In brief, the three-month AC regimen was equal in effectiveness to the six-month CMF regimen. CEF, also a 6-month regimen, was somewhat more
effectiveEffective strength cough syrup than CMF but was also associated with more toxicity. The other way to improve upon the efficacy of standard 4 cycles of AC chemotherapy is with the addition of 4 cycles of
paclitaxelPaclitaxel
Paclitaxel protein-bound chemotherapy. The sequential use of AC followed by
paclitaxelPaclitaxel
Paclitaxel protein-bound may be even more effective if given on an every 2-week schedule (which takes 4 months) rather than an every 3-week schedule (which takes 6 months). More recently, a study has suggested that a combination of docetaxel and cyclophosphamide, given for 4 cycles, may also represent an improvement over the AC combination. As you can see, there are a variety of regimens and we have listed only a few. The person best equipped to have this discussion with you is the oncologist who will know your situation and be able to discuss risks versus benefits in terms that can help you to decide whether and what chemotherapy is appropriate for you. As we learn more about the biology of breast cancer, there appear to be some individuals with strongy hormone sensitive tumors who are best treated with hormonal therapy and may not require chemotherapy. Newer prognostic tests such as the Oncotype DX assay may be helpful in sorting out who those individuals are.
Thanks. I know that it's my choice, but I just would like to find out what the 'standard' treatment is in the states. I personally think that FEC is a little 'harsh' for my kind of diagnosis.
Jen
Since you are HER2-, you are not a candidate for Herceptin, the targeted monoclonal antibody.
Your hormone receptors are high, so you will also likely be treated with an anti-estrogen such as Tamoxifen or Arimidex (post menopausal).
Good luck!
Thank you for your answer. I did list my factor and was hoping that you could tell me what the BEST option would me in my case.
Thanks
Jen
Thank you for your answer. I've been reading about AC, but I didn't even know that it was a 'common' chemo. It's all so confusing. Of course, I want what's best but mot when the risks outweigh the side effects.
Good luck to you, too.
Jen
Good luck
I live in England and FEC was commonly used when I was dx in 2003.
My tumour was invasive ductal, 2 cm, and I had 4/18 lymph nodes affected. Also had associated DCIS, both cribriform and comedo which were excised along with the tumour,under the Wide Local Excision. I had 6 x FEC and had no heart problems. Adriamycin is not commonly used in England because it is hard on the heart, so I think Jak may have confused the two different chemo regimes. I believe Taxol and Taxotere are now being used widely in the UK. We don't pay for chemo drugs or treatment in the UK, so the different costs of various chemos do not really come into play.
Your Oncologist is really the best person to advise you which chemo to have, as he has all the details.
Hope you soon get it sorted out.
Liz.
http://www.cancerdocchitown.blogspot.com